Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
RNAZ Transcode Therapeutics
0.565-0.055-8.87%
Close
02/07 16:00 ET
0.567+0.001+0.21%
Post Mkt Price 02/07 19:27 ET
High
0.590
Open
0.590
Turnover
158.58K
Low
0.560
Pre Close
0.620
Volume
275.51K
Post-Market
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
12 Health Care Stocks Moving In Thursday's Pre-Market Session
GainersTenax Therapeutics (NASDAQ:TENX) shares rose 153.2% to $4.28 during Thursday's pre-market session. The company's market cap stands at $9.8 million. Biophytis (NASDAQ:BPTS) stock rose 119.45% to
Top Premarket Decliners
07:47 AM EST, 02/02/2023 (MT Newswires) -- TeraWulf (WULF) shares slumped 33% premarket Thursday, a day after the company launched an underwritten public offering of common stock. OncoSec Medical (ONC
TransCode Therapeutics Offering 12M Shrs >RNAZ
Transcode Therapeutics Files to Sell 12M Shares of Common Stock
Sector Update: Health Care Stocks Edging Lower
01:41 PM EST, 02/01/2023 (MT Newswires) -- Health care stocks were narrowly lower this afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) both slipping 0.4%.
Traders Stay Cautious Ahead of Fed Rate Decision, Weighing on US Equity Futures
08:48 AM EST, 02/01/2023 (MT Newswires) -- US equities were set for a cautiously lower open Wednesday as traders looked ahead to the much-awaited monetary policy decision from the US Federal Reserve.
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
GainersQuoin Pharmaceuticals (NASDAQ:QNRX) stock rose 76.6% to $2.95 during Wednesday's pre-market session. The company's market cap stands at $14.2 million. TransCode Therapeutics (NASDAQ:RNAZ) stock
Why TransCode Therapeutics (RNAZ) Shares Are Trading Higher Today
TransCode Therapeutics Inc (NASDAQ:RNAZ) reported preclinical proof-of-mechanism studies with its immunotherapy candidate, TTX-RIGA, in melanoma.TTX-RIGA, a novel immunotherapeutic cancer candidate, i
Top Premarket Gainers
07:46 AM EST, 02/01/2023 (MT Newswires) -- Motorsport Games (MSGM) shares increased threefold, extending Tuesday's rally. Quoin Pharmaceuticals (QNRX) shares surged 78% following a 9.7% gain in the pr
TransCode Therapeutics (RNAZ): A Promising Cancer Play
TransCode Therapeutics Inc. (NASDAQ: RNAZ) is a promising biotech company that has been in and out of the market spotlight in recent weeks and months. Its specific area of focus is a specialization on metastatic disease, putting it at the forefront of cancer research. It boasts some key treatment candidates that show significant promise. Positive ...
Company Overview
More
TransCode Therapeutics, Inc. engages in the development and commercializing of diagnostics and therapeutics for the detection and treatment of cancer. The company was founded by Robert Michael Dudley, Zdravka Medarova, and Anna Moore in January 2016 and is headquartered in Boston, MA.
CEO： Mr. Robert Michael Dudley
Market： NASDAQ
Listing Date： 07/09/2021
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet